Quarterly Results

DR. DATASONS LABS LTD.

NSE : NABSE : 533412ISIN CODE : INE928K01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.290 (0 %)
PREV CLOSE ( ) 6.29
OPEN PRICE ( ) 6.29
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 6.29 (1397430)
VOLUME 802500
TODAY'S LOW / HIGH ( )6.29 6.29
52 WK LOW / HIGH ( ) 6.296.29
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1711.17
1140.3
2014.38
207.95
Total Expenditure
1658.98
1084.31
1914.12
221.2
PBIDT (Excl OI)
52.19
55.99
100.26
-13.25
Other Income
49.18
43.67
NA
78.33
Operating Profit
101.37
99.66
100.26
65.08
Interest
88.49
86.78
86.94
102.9
Exceptional Items
NA
NA
NA
NA
PBDT
12.88
12.88
13.32
-37.82
Depreciation
12.59
12.59
12.45
50.42
Profit Before Tax
0.29
0.29
0.87
-88.24
Tax
0.09
0.09
0.27
-26.66
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
0.2
0.2
0.6
-61.58
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
0.2
0.2
0.6
-61.58
Equity Capital
1052.59
533.72
533.72
316.55
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
0.00
0.00
0.01
-1.94
Calculated EPS (Annualised)
0.00
0.01
0.04
-7.78
No of Public Share Holdings
105259442
50953468
50753468
28486875
% of Public Share Holdings
100
95.47
95.09
89.99
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
3.04
4.91
4.97
-6.37
PBIDTM%
5.92
8.73
4.97
31.29
PBDTM%
0.75
1.12
0.66
-18.18
PBTM%
0.01
0.02
0.04
-42.43
PATM%
0.01
0.01
0.02
-29.61
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.